GlassScriptPhysician profile
Susan Ellis
NPI 1750706800
$14,016.69
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $161 · 2023: $244 · 2024: $2,730 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $1,529 · Food and Beverage: $772 · Consulting Fee: $330 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,798.00 |
| Travel and Lodging | $1,528.50 |
| Food and Beverage | $772.34 |
| Consulting Fee | $330.00 |
| Education | $299.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11,314.38 | 2021-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $2,364.57 | 2023-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $135.05 | 2024 | Lybalvi, Aristada |
| Abbvie INC. | $70.69 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.84 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $46.66 | 2024 | Cobenfy |
| Novo Nordisk INC | $19.50 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.00 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.